The first FDA approval for a machine learning application to be used in a clinical setting is a big step forward for AI and machine learning in healthcare and industry as a whole.
Arterys’s medical imaging platform has been approved to be put into use to help doctors diagnose heart problems. It uses a self-teaching artificial neural network which has learned from 1,000 cases so far, and will continue to improve its knowledge and understanding of how the heart works with each new case it examines.
In order to be approved by the US Food and Drug Administration (FDA), it had to pass tests to show it can produce results at least as accurately as humans are currently able to. The key difference though is that Arterys takes an average of 15 seconds to produce a result for one case, which a professional human analyst would expect to spend between 30 minutes to an hour working on.
By Bernard Marr | Forbes